Загрузка...
Practical considerations on the use of rituximab in autoimmune neurological disorders
Rituximab (Mabthera, Rituxan) is a chimeric human/murine monoclonal antibody against CD-20 surface antigen expressed on B-cells. Rituximab, by causing B-cell depletion, appears to be effective in several autoimmune disorders; it has been approved for rheumatoid arthritis and is a promising new agent...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002645/ https://ncbi.nlm.nih.gov/pubmed/21179602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285609356135 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|